Point Of Care Tests for Rapid IVD Diagnostics

showlist/point-of-care-tests, showlist/point-of-care-tests, 
Inquiry
Inquiry
Faster Decisions With Decentralized Diagnostic Testing

Faster Decisions With Decentralized Diagnostic Testing

Point of care tests bring diagnostic testing closer to patients in clinics, emergency departments, community healthcare centers, and decentralized laboratories. Jiuhe provides IVD solutions covering immunoassay, colloidal gold, and fluorescence-based testing for different clinical applications. Selected products are designed to deliver results within approximately 10–15 minutes, helping healthcare teams reduce waiting time during routine screening and urgent assessment. For distributors, a diversified portfolio can support applications including inflammation, cardiovascular risk, diabetes monitoring, infectious disease screening, and reproductive health. Applicable products can also support storage between 2–30°C, simplifying transportation and inventory management in many markets. This combination of rapid testing, flexible deployment, and broad application coverage makes point of care tests practical for expanding decentralized diagnostic services.
Get A Quote

Case Study

Rapid Testing in Emergency Care

An outpatient emergency clinic needed faster access to diagnostic information without sending every specimen to a centralized laboratory. The purchasing team introduced point of care tests for selected cardiovascular and inflammatory applications, creating a faster preliminary testing workflow. D-Dimer testing was particularly useful where timely risk assessment was required, with applicable products offering a reading time of approximately 15 minutes. Staff could perform testing closer to patients while maintaining a structured laboratory referral process for cases requiring additional confirmation. The project also benefited from practical storage requirements for applicable kits, supporting easier inventory management. This approach helped the clinic improve testing responsiveness and demonstrates how point of care tests can strengthen decentralized healthcare workflows when speed and accessibility are important.

Diabetes Monitoring in Outpatient Clinics

A regional healthcare distributor wanted to expand its diabetes-testing portfolio for outpatient clinics seeking convenient quantitative screening solutions. The distributor introduced HbA1c point of care tests to support routine diabetes monitoring without depending entirely on centralized laboratory services. A selected Jiuhe HbA1c product lists a reading time of around 15 minutes, making it suitable for consultations where clinicians need timely information. The distributor combined the test with other IVD products to create a broader diagnostic package for recurring clinic demand. This application model improved product positioning because sales discussions could focus on complete testing workflows rather than individual reagents. It also created opportunities for repeat purchasing across clinics with regular diabetes screening requirements and growing decentralized testing demand.

Decentralized Testing for Remote Markets

A medical distributor serving smaller hospitals and remote clinics needed diagnostic products that could operate outside large centralized laboratory environments. The purchasing team evaluated point of care tests covering metabolic, inflammatory, cardiovascular, and infectious disease applications. Colloidal gold products provided straightforward rapid-testing options, while fluorescence immunoassay platforms offered expanded quantitative testing capabilities for selected assays. Applicable products supporting 2–30°C storage helped simplify distribution planning where refrigerated infrastructure was limited. Instead of building a single-purpose product line, the distributor developed application-based packages according to local healthcare priorities and expected testing volumes. This strategy provided greater flexibility for regional deployment and allowed the distributor to address different clinical needs through one coordinated IVD portfolio.

Point of care tests require more than rapid reaction times; they depend on consistent reagent preparation, controlled materials, reliable signal development, clear instructions, and stable packaging. Jiuhe develops and supplies IVD products across immunoassay, colloidal gold, and fluorescence immunoassay technologies, supporting applications from routine screening to specialized clinical assessment. Its portfolio includes diagnostic kits and analyzer-based solutions designed for decentralized testing environments. Selected assays can provide results in approximately 10–15 minutes, helping healthcare providers shorten the interval between sample collection and preliminary evaluation. Applicable products can support 2–30°C storage, which can simplify logistics for distributors serving regions with limited cold-chain infrastructure. In practical applications, HbA1c can support diabetes monitoring, while D-Dimer, PCT/CRP, IL-6, and other assays address different cardiovascular and inflammatory testing needs. For international buyers, this broad portfolio enables application-specific product combinations, helping clinics, laboratories, and distributors build scalable point of care tests programs around actual market demand.

Frequently Asked Questions

What are point of care tests used for?

Point of care tests are used to perform diagnostic testing near patients instead of relying solely on centralized laboratories. Depending on the assay, they can support screening, monitoring, triage, or clinical assessment. Applications may include diabetes, inflammation, cardiovascular risk, infectious diseases, and reproductive health.
Result times vary according to the test format, sample type, analyzer, and operating conditions. Selected Jiuhe products list reading times of approximately 10–15 minutes. Buyers should confirm the latest product specifications and instructions for use before selecting a point of care testing solution.
Point of care tests can be used in hospitals, outpatient clinics, emergency departments, community healthcare centers, laboratories, and remote medical facilities. Their decentralized format is particularly useful where healthcare teams need faster access to preliminary diagnostic information without sending every sample to a central laboratory.
Jiuhe provides a range of IVD solutions using technologies including immunoassay, colloidal gold, and fluorescence immunoassay. Depending on the product portfolio, applications can include HbA1c, D-Dimer, inflammatory markers, infectious disease screening, and reproductive health testing for different healthcare environments.
They can support more flexible distribution when product storage and transportation requirements are suitable for the target market. Applicable Jiuhe products can support 2–30°C storage, reducing dependence on deep-frozen logistics. However, buyers should verify individual product requirements, regulatory status, and shipping conditions before procurement.

Related article

Accurate AMH Rapid Test Kit for Ovarian Reserve Assessment | Jiachuang Jiuhe

16

Sep

Accurate AMH Rapid Test Kit for Ovarian Reserve Assessment | Jiachuang Jiuhe

View More
How to Track Your Cycle Using an Ovulation Test Kit Effectively?

16

Sep

How to Track Your Cycle Using an Ovulation Test Kit Effectively?

Learn how to use an ovulation test kit step by step to track your cycle, detect the LH surge, and maximize your fertile window accuracy.
View More
Why Are Multi-Parameter Testing Kits Gaining Popularity in Preventive Health?

16

Sep

Why Are Multi-Parameter Testing Kits Gaining Popularity in Preventive Health?

Explore how multi-parameter testing kits improve preventive healthcare through early detection, faster diagnosis, and efficient medical testing solutions.
View More
Immunoassay Analyzer Solutions for Hospitals and Laboratories.

16

Sep

Immunoassay Analyzer Solutions for Hospitals and Laboratories.

Explore immunoassay analyzer solutions for hospitals and labs — selection criteria, reagent planning, compliance, and medical supplier guidance.
View More

Customer Testimonials

James Wilson

Our clinic reduced waiting time by using rapid testing products with results available in about 15 minutes, helping staff organize outpatient screening more efficiently during busy daily consultations.

Robert Miller

The product range helped us build several diagnostic packages for regional clinics, while 2–30°C storage requirements on applicable products made inventory planning easier across multiple locations.

Get a Free Quote

Our representative will contact you soon.
0/1000
Rapid Results for Decentralized Healthcare

Rapid Results for Decentralized Healthcare

Point of care tests can improve diagnostic workflows when clinicians need timely information close to patients. Selected Jiuhe products offer reading times of approximately 10–15 minutes, supporting practical use in outpatient clinics, emergency departments, and community healthcare programs. A clinic can select assays according to its patient population, such as HbA1c for diabetes monitoring or D-Dimer for cardiovascular and thrombotic-risk assessment. This application-based model helps healthcare teams reduce unnecessary waiting before preliminary decisions and allows distributors to create targeted product packages. For example, a regional distributor can combine several rapid assays with compatible testing platforms to serve different departments through one supply relationship. The result is a more flexible diagnostic workflow that connects testing speed with real clinical requirements.
Practical Storage for International Supply Chains

Practical Storage for International Supply Chains

International distribution requires diagnostic products that are practical to store, transport, and manage across different healthcare environments. Applicable Jiuhe point of care tests can support storage at 2–30°C, offering distributors greater flexibility where deep-freeze infrastructure is unavailable. This can be valuable for regional warehouses, community clinics, and remote healthcare projects where logistics directly affect product availability. Buyers can organize inventory according to testing demand, application, and expected turnover instead of maintaining unnecessarily complex storage systems. For example, a distributor supplying multiple outpatient clinics can combine metabolic, cardiovascular, and inflammatory assays within one regional inventory plan. By considering storage conditions alongside testing speed and clinical application, procurement teams can build more efficient and scalable diagnostic supply programs.